Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Coleman

Showing results (641-650 of 670) with videos related to

Pageof 67
Sort By:
Fetal Diagnosis and Therapy|February 28, 2026
Early Childhood Outcomes in Severe Congenital Diaphragmatic Hernia Treated with Fetoscopic Endoluminal Tracheal Occlusion (FETO) versus Non-FETO at a Single CenterSierra Land, Sabrina Flohr, Leny Mathew, et al.
Oncotarget|March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
The Journal of Investigative Dermatology|April 27, 2007
Isolation and expression of a Malassezia globosa lipase gene, LIP1Yvonne M DeAngelis, Charles W Saunders, Kevin R Johnstone, et al.
Genes and Immunity|October 31, 2008
CD226 Gly307Ser association with multiple autoimmune diseasesJ P Hafler, L M Maier, J D Cooper, et al.
Nature Medicine|April 16, 2026
Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinomaShahriar A Zamani, Lianlian Wu, Emily L Black, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
Radiology|November 6, 2019
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System CommitteeRochelle F Andreotti, Dirk Timmerman, Lori M Strachowski, et al.
BMJ Open|November 16, 2019
Development of a core information set for colorectal cancer surgery: a consensus studyAngus G K McNair, Robert N Whistance, Barry Main, et al.
Cancer Research|October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitorJitesh P Jani, Richard S Finn, Mary Campbell, et al.
Pageof 67

Showing results (641-650 of 670) with videos related to

Sort By:
Pageof 67
Fetal Diagnosis and Therapy|February 28, 2026
Early Childhood Outcomes in Severe Congenital Diaphragmatic Hernia Treated with Fetoscopic Endoluminal Tracheal Occlusion (FETO) versus Non-FETO at a Single CenterSierra Land, Sabrina Flohr, Leny Mathew, et al.
Oncotarget|March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
The Journal of Investigative Dermatology|April 27, 2007
Isolation and expression of a Malassezia globosa lipase gene, LIP1Yvonne M DeAngelis, Charles W Saunders, Kevin R Johnstone, et al.
Genes and Immunity|October 31, 2008
CD226 Gly307Ser association with multiple autoimmune diseasesJ P Hafler, L M Maier, J D Cooper, et al.
Nature Medicine|April 16, 2026
Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinomaShahriar A Zamani, Lianlian Wu, Emily L Black, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
Radiology|November 6, 2019
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System CommitteeRochelle F Andreotti, Dirk Timmerman, Lori M Strachowski, et al.
BMJ Open|November 16, 2019
Development of a core information set for colorectal cancer surgery: a consensus studyAngus G K McNair, Robert N Whistance, Barry Main, et al.
Cancer Research|October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitorJitesh P Jani, Richard S Finn, Mary Campbell, et al.
Pageof 67